Journal of Nuclear Medicine: 57 (4)

About the Cover

April 1, 2016; Volume 57,Issue 4

Cover image

A study in this issue presents pilot data on ⁶⁸Ga-PSMA and ⁶⁸Ga-RM2, two tracers with distinct biodistributions in patients with biochemically recurrent prostate cancer. See page 557.

In this issue

Issue highlights

Interventional Molecular Imaging
RGD PET: From Lesion Detection to Therapy Response Monitoring
Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer
Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients

MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [¹⁷⁷Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
Prediction of ¹⁷⁷Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections

More...

Main menu

User menu

Search

About the Cover

Cover image

In this issue

Issue highlights

Jump to